, Tracking Stock Market Picks
Enter Symbol:
Accentia Biopharmaceuticals, Inc (ABPI) [hlAlert]

up 20,900.00 %

Accentia Biopharmaceuticals, Inc. (ABPI) rated Underperform with price target $0.55 by Jefferies & Co

Posted on: Tuesday,  Mar 25, 2008  8:25 AM ET by Jefferies & Co

Jefferies & Co rated Underperform Accentia Biopharmaceuticals, Inc. (OTCBB: ABPI) on 03/25/2008, when the stock price was $0.84.
Since then, Accentia Biopharmaceuticals, Inc. has lost 99.52% as of 08/27/2015's recent price of $0.00.
If you would have followed this Jefferies & Co's recommendation on ABPI, you would have gained 20900% of your investment in 2711 days.

Our focus on growing and mid-sized companies enables us to identify unique investment ideas, which can make the difference in a tough market. Jefferies' research effort covers U.S. & International equity, high yield, convertibles, investment grade fixed income and post-reorganization securities, as well as special situations and quantitative research. The more than 120-person team of research professionals covers over 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes and dig deeper to provide in-depth, thought provoking, objective research. Our analysts use a variety of quantitative and qualitative tools, integrating field analysis, proprietary channel checks and ongoing dialogue with the managements of the companies they cover. We utilize the latest technologies to deliver a research product that is timely, differentiated, and tailored to each customer's needs. Regular client access to companies and their management teams is provided through a wide variety of Jefferies hosted industry conferences, company management meetings and on-site tours.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy